Fresenius Files Tocilizumab Biosimilar With EMA

Follows Earlier Announcement Of Kabi’s US FDA Filing For Actemra/RoActemra Rival

 
• By David Wallace
  
EU US Cogs Flags
Fresenius has now submitted tocilizumab in both the US and EU • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products